Published in Experientia on January 15, 1983
Adriamycin and altered membrane functions in rat hearts. Br J Exp Pathol (1986) 0.80
Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet (2015) 7.29
Mycobacterium bovis infections in San Diego: a clinicoepidemiologic study of 73 patients and a historical review of a forgotten pathogen. Medicine (Baltimore) (1993) 2.59
Age- and sex-specific antibiotic prescribing patterns in general practice in England and Wales in 1996. Br J Gen Pract (1999) 2.44
Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies. Lancet Oncol (2012) 2.33
A new oscillometric method for pulse wave analysis: comparison with a common tonometric method. J Hum Hypertens (2010) 2.19
Mortality in women in relation to their childbearing history. BMJ (1988) 2.06
Factors influencing the attendance rate at accident and emergency departments in East London: the contributions of practice organization, population characteristics and distance. J Health Serv Res Policy (1997) 1.96
Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation. Genes Immun (2004) 1.77
Cefazolin concentrations in bone and synovial fluid. J Bone Joint Surg Am (1978) 1.70
Age, sex and practice variations in the use of statins in general practice in England and Wales. J Public Health Med (2000) 1.60
Tryptophanase in diverse bacterial species. J Bacteriol (1969) 1.56
Development of housing programs to aid in the treatment of tuberculosis in homeless individuals: a pilot study. Chest (1999) 1.46
Further evidence for lymphokine overproduction in severe aplastic anemia. Blood (1988) 1.43
Catabolism of 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) by isolated rat hearts. Eur J Nucl Med (1990) 1.39
Glycosylated hemoglobins (GHb): an index of red cell survival. Blood (1982) 1.32
A study of tuberculosis among foreign-born Hispanic persons in the U.S. States bordering Mexico. Am J Respir Crit Care Med (1999) 1.24
Gastrointestinal transit, release and plasma pharmacokinetics of a new oral budesonide formulation. Br J Clin Pharmacol (2006) 1.22
Drug-resistant pulmonary tuberculosis in the Baja California-San Diego County border population. West J Med (1998) 1.14
Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7. Virology (1991) 1.14
Clinical in vitro endothelialization of femoropopliteal bypass grafts: an actuarial follow-up over three years. J Vasc Surg (1994) 1.11
Stimulation of immune response in lung cancer patients by vitamin A therapy. Oncology (1977) 1.08
FDG-PET in adrenocortical carcinoma. Cancer Biother Radiopharm (2001) 1.07
Relation of rates of self referral to A&E departments to deprivation. Robust markers are needed of variations in case mix among practices. BMJ (1998) 1.04
Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation. Leukemia (2002) 1.03
Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase. Br J Cancer (2004) 1.02
Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C. Int J Cancer (1999) 1.01
Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer. Cancer (1990) 1.00
Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. Am J Pathol (1999) 1.00
Immunosuppression by human placenta lactogen (HPL) and the pregnancy-specific beta 1-glycoprotein (SP-1). Inhibition of mitogen-induced lymphocyte transformation. Arch Gynakol (1977) 1.00
YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc. Oncogene (1998) 1.00
Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma. Q J Nucl Med Mol Imaging (2004) 1.00
Management of tuberculosis in San Diego County: a survey of physicians' knowledge, attitudes and practices. Int J Tuberc Lung Dis (2001) 0.99
Letter: Reverse transcriptase in plasma of patients with breast cancer. Lancet (1974) 0.98
Predictive value of thallium-201-dipyridamole myocardial stress scintigraphy in chronic hemodialysis patients and transplant recipients. Clin Nephrol (1991) 0.98
c-myc and functionally related oncogenes induce both high rates of sister chromatid exchange and abnormal karyotypes in rat fibroblasts. Curr Top Microbiol Immunol (1986) 0.97
FDG positron emission tomographic, radioiodine, and MIBI imaging in a patient with poorly differentiated insular thyroid carcinoma. Clin Nucl Med (2001) 0.96
Simultaneous and sequential determinations of steroid hormone receptors in human breast cancer. Influence of intervening therapy. Ann Surg (1985) 0.94
[Heterogeneity and organ distribution of alcohol dehydrogenase in various species]. Enzymol Biol Clin (Basel) (1968) 0.93
The use and overlap of AED and general practice services by patients registered at two inner London general practices. Br J Gen Pract (1998) 0.93
Cervical smear uptake rates. BMJ (1994) 0.93
Australia's notifiable diseases status, 1997. Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell (1999) 0.92
Social, economic, and psychological impacts of MDR-TB treatment in Tijuana, Mexico: a patient's perspective. Int J Tuberc Lung Dis (2013) 0.92
Severe hyperglycemia: effects of rehydration on endocrine derangements and blood glucose concentration. Diabetes (1979) 0.92
Elevated expression of an exogenous c-myc gene is insufficient for transformation and tumorigenic conversion of established fibroblasts. Oncogene (1987) 0.92
ADP-ribosylation of wild-type p53 in vitro: binding of p53 protein to specific p53 consensus sequence prevents its modification. Biochem Biophys Res Commun (1996) 0.92
Colonic spread and serum pharmacokinetics of budesonide foam in patients with mildly to moderately active ulcerative colitis. Aliment Pharmacol Ther (2005) 0.91
Uptake of (18)F-FLT and (18)F-FDG in primary head and neck cancer correlates with survival. Nuklearmedizin (2008) 0.91
ADP-ribosylation of p53 tumor suppressor protein: mutant but not wild-type p53 is modified. J Cell Biochem (1996) 0.91
Effects of chemotherapeutic agents on expression of somatostatin receptors in pancreatic tumor cells. J Nucl Med (2001) 0.91
Dermatitis herpetiformis is associated with atrophic but not with goitrous variant of Hashimoto's thyroiditis. Eur J Clin Invest (2000) 0.90
Characterization of (123)I-vascular endothelial growth factor-binding sites expressed on human tumour cells: possible implication for tumour scintigraphy. Int J Cancer (2001) 0.90
Hypertension in women: the role of progesterone and aldosterone. Climacteric (2010) 0.90
Linkage analysis of angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and systemic lupus erythematosus. Mol Cell Endocrinol (2001) 0.88
Imaging gastrointestinal tumours using vascular endothelial growth factor-165 (VEGF165) receptor scintigraphy. Ann Oncol (2003) 0.88
Regulation of cell growth by the Myc-Max-Mad network: role of Mad proteins and YY1. Curr Top Microbiol Immunol (1997) 0.88
Pulmonary angiography in severe chronic pulmonary hypertension. Ann Intern Med (1987) 0.88
Experience with indium-111 and yttrium-90-labeled somatostatin analogs. Curr Pharm Des (2002) 0.88
[The marble bone disease of the adult (M. Albers-Schönberg, osteopetrosis). II. Biochemical studies]. Klin Wochenschr (1967) 0.88
Natural killer cell activity in patients with multiple sclerosis: interferon and plasmapheresis. Immunobiology (1982) 0.88
[Immunological investigations in lichen planus patients (author's transl)]. Arch Dermatol Res (1976) 0.87
Promotion of sterol efflux and net transport by apolipoprotein E in lecithin:cholesterol acyltransferase deficiency. Metabolism (1982) 0.87
Nuclear Ras: unexpected subcellular distribution of oncogenic forms. J Cell Biochem Suppl (2001) 0.86
The clinical course of lung metastases from breast cancer. Klin Wochenschr (1988) 0.86
Rapid assessment of human immunodeficiency virus seroprevalence in a community-based hospital. Am J Infect Control (1993) 0.86
In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram. Psychopharmacology (Berl) (2006) 0.86
Radioactive contamination of contact lenses during radioiodine therapy. Nucl Med Commun (2000) 0.86
Toxicity and response to high-dose ifosfamide + mesna as salvage therapy for advanced breast cancer. J Cancer Res Clin Oncol (1988) 0.86
Blood pressure responses after carotid surgery: relationship to postoperative baroreceptor sensitivity. Am J Med (1993) 0.85
Bioequivalence of subcutaneous calcium and sodium heparins. Clin Pharmacol Ther (1980) 0.85
Six independent domains are defined by geriatric assessment in elderly cancer patients. Crit Rev Oncol Hematol (2009) 0.85
[Oestrogen receptors and prognosis in breast cancer]. Wien Klin Wochenschr (1980) 0.84
Effect of calculation stress on hemodynamics and plasma catecholamines before and after beta-blockade with propranolol (Inderal) and mepindolol sulfate (Corindolan). Eur J Clin Pharmacol (1979) 0.84
Sodium cephapirin disposition and distribution into human bone. Curr Ther Res Clin Exp (1976) 0.84
The cytoplasmic truncated receptor tyrosine kinase ALK homodimer immortalizes and cooperates with ras in cellular transformation. FASEB J (2001) 0.83
Subcellular localisation of Cdc25A determines cell fate. Cell Death Differ (2004) 0.83
[Hexokinase deficiency in hemolytic anemia]. Med Welt (1970) 0.83
Sialyl transferase activity: a serum enzyme marker in the follow-up of cancer patients. Recent Results Cancer Res (1979) 0.83
Acute cardiac toxicity in patients after doxorubicin treatment and the effect of combined tocopherol and nifedipine pretreatment. J Cancer Res Clin Oncol (1983) 0.83
Positioning of vagal nerve stimulators: technical note. Surg Neurol (2000) 0.83
Indium-111-labeled platelet scintigraphy in carotid atherosclerosis. Stroke (1989) 0.83
The human tumour cloning assay in the management of breast cancer patients. Br J Cancer (1985) 0.82
Evidence for the separation of albumin- and apo A-I-dependent mechanisms of cholesterol efflux from cultured fibroblasts into human plasma. J Biol Chem (1982) 0.82
111In-DOTA-lanreotide scintigraphy in patients with tumors of the lung. J Nucl Med (2001) 0.82
Tumorigenic transformation of rat FR3T3 fibroblasts carrying an activated myc oncogene requires subsequent mutational events. Oncogene Res (1988) 0.82
Influence of PET reconstruction parameters on the TrueX algorithm. A combined phantom and patient study. Nuklearmedizin (2013) 0.82
Function of the autonomic nervous system in patients with hepatic encephalopathy. Hepatology (1985) 0.82
The diltiazem-digoxin interaction. Clin Pharmacol Ther (1984) 0.82
Plasmapheresis in the management of psoriasis. Arch Dermatol Res (1985) 0.82
Carcinoembryonic antigen (CEA) plasma level determination in the management of gastric cancer patients. Cancer Detect Prev (1985) 0.82
Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume? Clin Exp Immunol (2003) 0.82
Value of combined XCT/SPECT technology for avoiding false positive planar (123)I-MIBG scintigraphy. Nuklearmedizin (2004) 0.81
18F-fluorodeoxyglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liver. Liver (2000) 0.81
Non-selective analysis of the transformation of FR3T3 rat cells by bovine papillomavirus type 1: regulations of viral transcription associated with phenotypic transformation. Oncogene (1990) 0.81
[On progressive myopathy with muscle phosphorylase deficiency and giant mitochondria]. Wien Klin Wochenschr (1967) 0.81
Cdc25A phosphatase suppresses apoptosis induced by serum deprivation. Oncogene (2001) 0.81